Mirae Asset Healthcare Fund Direct Growth
NAV as on 17-04-2025
₹ 40.21
▲0.7%
1D
Inception Returns
22.4%
/yr
Historical NAV & Returns
Absolute
▲
▼
3015 people have invested ₹ 2.2Cr in Mirae Asset Healthcare Fund Direct Growth in the last three months
About Mirae Asset Healthcare Fund Direct Growth
Mirae Asset Healthcare Fund Direct Growth is an equity fund. This fund was started on 2 June, 2018. The fund is managed by Vrijesh Kasera. The fund could potentially beat inflation in the long-run.
Key Parameters
- Mirae Asset Healthcare Fund Direct Growth has ₹2667 Cr worth of assets under management (AUM) as on Mar 2025 and is more than category average.
- The fund has an expense ratio 0.6.
Returns
Mirae Asset Healthcare Fund Direct Growth has given a CAGR return of 22.43% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 19.17%, 18.66% and 24.93% respectively.
Holdings
Mirae Asset Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials, Industrial. Its top holdings are Sun Pharmaceuticals Industries Ltd, Aurobindo Pharma Ltd, Cipla Ltd, Divi's Laboratories Ltd, Lupin Ltd
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
Investment objective of Mirae Asset Healthcare Fund Direct Growth
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 99.00. Mirae Asset Healthcare Fund Direct Growth has no lock in period.
Mirae Asset Healthcare Fund Direct Growth Overview
| Expense ratio | 0.61% |
Benchmark | BSE Healthcare TR INR |
| AUM | ₹2667 Cr |
| Inception Date | 2 June, 2018 |
| Min Lumpsum/SIP | ₹5000/₹99 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 18.15% |
| STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
INDmoney Rank for Mirae Asset Healthcare Fund Direct Growth
Powered by IND quant engine
IND ranking is not available for this fund.
Lower expense ratio
Beats FD returns for both 3Y & 5Y duration
3Y returns in the bottom 25% of the category
Trailing Returns
as on (17-Apr-25)
Fund Distribution
as on (31-Mar-25)
Mid cap
39.6%
Large cap
33%
Small cap
23.9%
Sector Allocation
Health
98.7%
Basic Materials
1.3%
Industrial
0%
All changes are between Jan'25 and Mar'25
- This fund’s returns stands at 9.16% whereas the fund’s underlying benchmark Nifty 500 returns stands at 7.25% as on Mar'25
- This fund outperformed Nifty 500 by 1.91% in Mar'25
- AUM of the fund stands at 2.7K Cr as of Mar'25
- AUM increased by 226.3 Cr between Mar'25 and Feb'25
Top Stocks bought last month
Krishna Institute of Medical Sciences Ltd's allocation increased from 3.57% to 4.13%
OneSource Specialty Pharma Ltd's allocation increased from 1.87% to 2.43%
Deepak Nitrite Ltd's allocation increased from 0.15% to 0.7%
Top Stocks sold last month
Cipla Ltd's allocation decreased from 7.6 % to 6.91 %
Lupin Ltd's allocation decreased from 6.36 % to 6.2 %
Dr Reddy's Laboratories Ltd's allocation decreased from 6.36 % to 4.15 %
Mid Cap allocation has gone up from 39% to 39.6%
Large Cap allocation has gone down from 34.4% to 33%
Small Cap allocation has gone up from 23.8% to 23.9%
Cash allocation has gone up from 0.4% to 0.4%
Top 3 Sectors in March were Health, Basic Materials & Industrial
Mar'25
Health
99%
Basic Materials
1%
Feb'25
Health
99%
Basic Materials
Industrial
Holdings | Weight% | 1M Change | |
|---|---|---|---|
 Sun Pharmaceuticals Industries Ltd | 11.9% | 0.9% | |
 Aurobindo Pharma Ltd | 7.12% | 0% | |
 Cipla Ltd | 6.91% | -3% | |
 Divi's Laboratories Ltd | 6.6% | 4.7% | |
 Lupin Ltd | 6.2% | 0% |
See all
Funds | 1Y Returns | 3Y Returns | 5Y Returns | Since Inception |
|---|---|---|---|---|
Mirae Asset Healthcare Fund Direct Growth | 19.17% | 18.66% | 24.93% | 22.43% |
 UTI Healthcare Fund-Growth Option- Direct | 22.13% | 20.25% | 23.63% | 16.18% |
 SBI Healthcare Opportunities Fund Direct Growth | 21.64% | 23.93% | 26.46% | 18.24% |
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth | 21.02% | 23.46% | 26.57% | 22.41% |
See all
Top Growth Drivers | 1M Return |
|---|---|
 Krishna Institute of Medical Sciences Ltd | 10.9% |
 Sun Pharmaceutical Industries Ltd | 1.1% |
Loading...
We are taking more time than usual
Vrijesh Kasera
Fund Manager of Mirae Asset Healthcare Fund Direct Growth, since 2 July 2018
Top funds managed
Fund House
Mirae Asset Investment Managers (India) Private Limited
Total Schemes
Total AUM
₹1.68L Cr
as on 31-Mar-2025
Address
Mirae Asset Investment Managers (India) Private Limited.,Unit No. 606, 6th Floor,,Windsor Bldg, Off CST Road,,Kalina, Santacruz (East), Mumbai - 400 098
Phone
91-22-22-6780300
Website
customercare@miraeasset.com
Mutual Fund Insights
Over the last 1 month, this fund has increased expense ratio by 38.6% moving from 0.44 to 0.61.
In the last 5 years, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has given 26.57% return, outperforming this fund by 1.64% per annum.
This fund has one of the lowest expense ratio in the category (sector - healthcare). Its expense ratio is 0.61% which is lower than the category average expense ratio of 1.41%.
In the last 3 years, SBI Healthcare Opportunities Fund Direct Growth has given 23.93% return, outperforming this fund by 5.27% per annum.
Over the last 1 month, this fund has experienced a 9.3% growth in AUM moving from 2.44K Cr to 2.66K Cr.
In the last 1 year, HDFC Pharma and Healthcare Fund Direct Growth has given 29.31% return, outperforming this fund by 10.14%.
Mirae Asset Healthcare Fund Direct Growth Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 22.43% since inception which is more than its category average return of 17.07%
Fund Allocations
This fund has an allocation of 99.55% in Equity, 0% in Debt and 0.45% in Cash related instruments
AUM size ₹2667 Cr
This fund has AUM of ₹2667 Cr which is more than its category average of ₹ 1821 Cr
Expense Ratio 0.61%
This fund has an expense ratio of 0.61% which is less than its category average expense ratio of 1.44%
Most Popular Comparisons
- Compare
Mirae Asset Healthcare FundVs
Nippon India Pharma Fund Direct Growth
- Compare
- Mirae Asset Healthcare FundVs
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
- Compare
- Mirae Asset Healthcare FundVs
SBI Healthcare Opportunities Fund Direct Growth
- Compare
- Mirae Asset Healthcare FundVs
DSP Healthcare Fund Direct Growth
- Compare
- Mirae Asset Healthcare FundVs
UTI Healthcare Fund Direct Growth
Frequently Asked Questions for Mirae Asset Healthcare Fund Direct Growth
The current NAV of Mirae Asset Healthcare Fund Direct Growth is ₹40.21 as on 17-Apr-2025.
Existing (Absolute + CAGR) as on 17-Apr-2025.
Mirae Asset Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 3.82% | 3.82% |
6 Month Returns | -6.75% | -6.75% |
1 Year Returns | 19.17% | 19.17% |
3 Years Returns | 67.08% | 18.66% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
0.61% as on March 2025
₹2667 Cr as on March 2025
Sun Pharmaceuticals Industries Ltd(11.9%), Aurobindo Pharma Ltd(7.12%), Cipla Ltd(6.91%), Divi's Laboratories Ltd(6.6%), Lupin Ltd(6.2%) as on March 2025
Health(98.25%), Basic Materials(1.3%), Industrial(0%) as on March 2025
The alpha ratio for the Mirae Asset Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
Mirae Asset Healthcare Fund Direct Growth | -0.17 | -0.36 | 1.37 |
As on March 2025
The alpha for Mirae Asset Healthcare Fund Direct Growth is calculated against BSE Healthcare TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Mirae Asset Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
Mirae Asset Healthcare Fund Direct Growth | 1.04 | 0.98 | 0.99 |
As on March 2025
The Beta for Mirae Asset Healthcare Fund Direct Growth is calculated with BSE Healthcare TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Mirae Asset Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
Mirae Asset Healthcare Fund Direct Growth | 0.61 | 0.76 | 1.15 |
As on March 2025
The sharpe ratio for Mirae Asset Healthcare Fund Direct Growth is calculated with BSE Healthcare TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Mirae Asset Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
Mirae Asset Healthcare Fund Direct Growth | 21.01 | 17.14 | 20.07 |
As on March 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.34 as on March 2025. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Vrijesh Kasera is the fund manager of Mirae Asset Healthcare Fund Direct Growth
The Exit load of Mirae Asset Healthcare Fund Direct Growth is 1%